Saturday, June 20, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 373 of 1,261
  1. WO 2021001362

    LIGANDS D'ANTIGÈNE MEMBRANAIRE SPÉCIFIQUE DE LA PROSTATE (PSMA) ET LEURS UTILISATIONS

    ADVANCED ACCELERATOR APPLICATIONS ITALY SRL [IT] · Granted Jan 7, 2021 · Expires Jan 2, 2041

    granted
  2. CA 3144557

    LIGANDS D'ANTIGENE MEMBRANAIRE SPECIFIQUE DE LA PROSTATE (PSMA) ET LEURS UTILISATIONS

    ADVANCED ACCELERATOR APPLICATIONS ITALY SRL [IT] · Granted Jan 7, 2021 · Expires Jan 2, 2041

    granted
  3. US 10881684

    Artificial invaplex formulated with deacylated lipopolysaccharide

    United States Government as represented by the Secretary of the Army · Granted Jan 5, 2021 · Expires Dec 31, 2040

    granted
  4. US 10883117

    Adeno-associated virus variants and methods of use thereof

    The Regents of the University of California · Granted Jan 5, 2021 · Expires Dec 31, 2040

    granted
  5. US 10881644

    Treatment of asthma and chronic obstructive pulmonary disease with anti-proliferate and anti-inflammatory drugs

    Lutonix, Inc. · Granted Jan 5, 2021 · Expires Dec 31, 2040

    granted
  6. US 10881708

    Ang (1-7) derivative oligopeptides for the treatment of pain

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Jan 5, 2021 · Expires Dec 31, 2040

    granted
  7. US 10881646

    Methods and compositions for treating non-ERK MAPK pathway inhibitor-resistant cancers

    Biomed Valley Discoveries, Inc. · Granted Jan 5, 2021 · Expires Dec 31, 2040

    granted
  8. US 10882886

    Adeno-associated virus polynucleotides, polypeptides and virions

    THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (WASHINGTON DC) · Granted Jan 5, 2021 · Expires Dec 31, 2040

    granted
  9. US 10882895

    Nucleic acid encoding angiopoietin-2 specific Tie2 receptor

    United Kingdom Research and Innovation · Granted Jan 5, 2021 · Expires Dec 31, 2040

    granted
  10. US 10883107

    Polynucleotide agents targeting factor XII (hageman factor) (F12) and methods of use thereof

    Alnylam Pharmaceuticals, Inc. · Granted Jan 5, 2021 · Expires Dec 31, 2040

    granted
  11. US 10883104

    Compositions and methods for modulating apolipoprotein (a) expression

    Ionis Pharmaceuticals, Inc. · Granted Jan 5, 2021 · Expires Dec 31, 2040

    granted
  12. US 10883119

    Methods and compositions for delivery of biologics

    Sangamo Therapeutics, Inc. · Granted Jan 5, 2021 · Expires Dec 31, 2040

    granted
  13. US 10883980

    Methods and compositions for inhibiting hepatitis E virus

    THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Jan 5, 2021 · Expires Dec 31, 2040

    granted
  14. US 10883094

    Transposase polypeptides and uses thereof

    The Board of Regents of the University of Texas System · Granted Jan 5, 2021 · Expires Dec 31, 2040

    granted
  15. US 10882903

    Methods and compositions for treating an alphavirus infection

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Jan 5, 2021 · Expires Dec 31, 2040

    granted
  16. US 10881748

    Nitroxide containing amyloid binding agents for imaging and therapeutic uses

    The Regents of the University of California · Granted Jan 5, 2021 · Expires Dec 31, 2040

    granted
  17. US 10881742

    Factor VIII chimeric and hybrid polypeptides, and methods of use thereof

    BIOVERATIV THERAPEUTICS INC. · Granted Jan 5, 2021 · Expires Dec 31, 2040

    granted
  18. US 10881735

    Phase change nanodroplet conjugates for targeted delivery

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Jan 5, 2021 · Expires Dec 31, 2040

    granted
  19. US 10881722

    Epizootic hemorrhagic disease vaccine

    The United States of America, as represented by the Secretary of Agriculture · Granted Jan 5, 2021 · Expires Dec 31, 2040

    granted
  20. US 10881714

    Methods and compositions for oral administration of proteins

    Oramed Ltd. · Granted Jan 5, 2021 · Expires Dec 31, 2040

    granted
  21. US 10881738

    Oligomer-beta blocker conjugates

    Nektar Therapeutics · Granted Jan 5, 2021 · Expires Dec 31, 2040

    granted
  22. US 10881720

    Nanoparticles for immune stimulation

    The Board of Regents of the University of Texas System · Granted Jan 5, 2021 · Expires Dec 31, 2040

    granted
  23. US 10881698

    Diagnosis and treatment for respiratory tract diseases

    United States Government as represented by the Department of Veterans Affairs · Granted Jan 5, 2021 · Expires Dec 31, 2040

    granted
  24. US 10881689

    Materials and methods for engineering cells and uses thereof in immuno-oncology

    CRISPR THERAPEUTICS AG · Granted Jan 5, 2021 · Expires Dec 31, 2040

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.